Curriculum vitae

Aquí te dejo las referencias de los trabajos más relevantes publicados por mí en fibromialgia, con una conexión directa para que puedas leerlos si te interesan.

  1. Rivera J, Tercero MJ, Salas JS, Gimeno JH, Alejo JS. The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin. Rheumatol Int. 2018 Dec;38(12):2243-2250.
  2. Rivera J, Vallejo MA. Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study. Rheumatol Int. 2016 Dec;36(12):1691-1699.
  3. Vallejo MA, Ortega J, Rivera J, Comeche MI, Vallejo-Slocker L. Internet versus face-to-face group cognitive-behavioral therapy for fibromyalgia: A randomized control trial. J Psychiatr Res. 2015 Sep;68:106-13.
  4. Rivera J. (Varios autores por orden alfabético). Guía de debut en fibromialgia. 2015. www.fibro.info.
  5. Rivera J, Vallejo MA, Offenbächer M. Classifying fibromyalgia patients according to severity: the combined index of severity in fibromyalgia. Rheumatol  Int. 2014 Dec;34(12):1683-9.
  6. Collado A, Gómez E, Coscolla R, Sunyol R, Solé E, Rivera J, Altarriba E, et al. Work, family and social environment in patients with Fibromyalgia in Spain. An epidemiological study: EPIFFAC Study. BMC Health Services Research 2014. Nov 11;14(1):513.
  7. Docampo E, Escaramís G, Gratacòs M, Villatoro S, Puig A, Kogevinas M, Collado  A, Carbonell J, Rivera J, Vidal J, Alegre J, Estivill X, Rabionet R. Genome-wide  analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system. Pain. 2014 Jun;155(6):1102-9.
  8. Rivera J, Vallejo MÁ, Esteve-Vives J; Grupo ICAF. Drug prescription strategies in the treatment of patients with fibromyalgia. Reumatol Clin. 2012 Jul-Aug;8(4):184-8.
  9. Rivera J, Esteve-Vives J, Vallejo MA, Rejas J; Grupo ICAF. Factors associated with temporary work disability in patients with fibromyalgia. Rheumatol Int. 2011 Nov;31(11):1471-7.
  10. Rivera J, Rejas J, Esteve-Vives J, Vallejo MA; Groupo ICAF. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain. Clin Exp Rheumatol. 2009 Sep-Oct;27(5 Suppl 56):S39-45.
  11. Rivera J. Medicina y Fibromialgia. En: Asociación Vasca de Divulgación de Fibromialgia, editor. “Guía de ejercicios para personas con fibromialgia”. pp 13-28. ISBN:978-84-692-2868-5. Vitoria 2009.
  12. Branco JC, Zachrisson O, Perrot S, Mainguy Y; Multinational Coordinator Study Group. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol. 2010 Apr;37(4):851-9.
  13. Rivera J. Tratamiento farmacológico en la fibromialgia. Inf Ter Sist Nac Salud 2008; 32: 107-115.
  14. Rivera J, Alegre C, Ballina  F, Carbonell J, Carmona L, Castel B, Collado, A, Esteve X, Martínez F, Tornero J, Vallejo MA, Vidal J. Documento consenso de Sociedad Española de Reumatología sobre la fibromialgia. Reumatol Clin 2006;2 (Supl 1):S55-66.
  15. Rivera J, Alegre C, Nishishinya MB, Pereda CA. Evidencias terapéuticas en fibromialgia. Reumatol Clin. 2006;2 (Supl 1):S34-37.
  16. Rivera J, González T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp  Rheumatol. 2004 Sep-Oct;22(5):554-60.
  17.  Rivera J, Justo CM, Moraleda FV, Velayos YG, Puche JJ, Zubero JR, Hernández  TG, Ortells LC, Pareja MA. Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach. Arthritis Rheum. 2004 Apr 15;51(2):184-92.
  18. Rivera J. Controversias en el diagnóstico de fibromialgia.Rev Esp Reumatol 2004;31:501-6.
  19. Rivera J, de Diego A, Trinchet M, García Monforte A. Fibromyalgia-associated  hepatitis C virus infection. Br J Rheumatol. 1997 Sep;36(9):981-5.